SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: Shane Miller who wrote (7274)1/27/1999 11:35:00 AM
From: vestor  Read Replies (1) | Respond to of 8359
 
Goldman Sachs ABTX presentation in NYC on 2/2..... confirmed... Many analysts and mutual fund mgrs to be present..... Thoughts on impact ? am being told the Goldman invite is not easy to get....



To: Shane Miller who wrote (7274)1/27/1999 12:38:00 PM
From: jerry carlson  Respond to of 8359
 
Shane
Yes, Celebrex is the new arthritis drug, and there was news out yesterday about early (large) subscriptions. I don't consider this off topic for abtx because MTC dropped out of the picture in the bidding for abtx because of a financial squeeze after their merger with Home Products fell through, IMHO. See the SI thread on MTC.
Jerry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News